Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas

Archives of Pathology and Laboratory Medicine

Volumn 121, Issue 4, 1997, Pages 404-410

  Tampanaru Sarmesiu, Alina ^a   Stefaneanu, Lucia ^a   Thapar, K ^a   Kovacs, K ^b   Donnelly, T ^a   Metz, C N ^a   Bucala, R ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ARTICLE; CORTICOTROPIN RELEASE; GONADOTROPIN RELEASE; HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; INFLAMMATION; MACROPHAGE MIGRATION; MAJOR CLINICAL STUDY; THYROTROPIN RELEASE;

ADENOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGE MIGRATION-INHIBITORY FACTORS; PITUITARY GLAND; PITUITARY NEOPLASMS;

EID: 0030942452     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bloom BR, Bennclt B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 1966;153:80-82.
2. David J. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA. 1966;56:72-77.
3. Nathan CF, Karnovslcy ML, David JR. Alterations of macrophage functions by mediators from lymphocytes. J Exp Mod. 1971,-133:1356-1376.
4. Nathan CF, Remold HG, David JR. Characterization of a lymphocyte factor which alters macrophage function. J Exp Med. 1973;137:275-288.
5. Churchill WH, Piessens WF, Sulis CA, David JR. Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells. 1 Immunol. 1975;1 15:781-785.
6. Harriott MJ, Leu RW. Activation of mouse macrophages for migration inhibition and for tumor cytotoxicity is mediated by interferon-gamma priming and triggering by various agents. J. Interferon Res. 1993;7:165-169.
7. Mclnnes A, Rennick DM. Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells. J Exp Med. 1988;167:598-611.
8. Thurman GB, Braude IA, Gray PW, Oldham RK, Stevenson HC. MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody. J Immunol. 1985;134:305-309.
9. Weiser WY, Temple PA, Witek-Giannotti )S, Remold HG, Clark SC, David JR. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci USA. 1989;86:7522-7526.
10. Bernhagen J, Calandra T, Mitchell RA, et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature. 1993;365:756-759.
11. Nishino T, Bemhagen J, Shiiki H, Calandra T, Dohi K, Bucala R. Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol Med. 1995;1 (71:781-788.
12. Hsu SM, Raine L, Fanger M. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981.-29:577-580.
13. Calandra T, Bemhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med. 1994;1 79:1895-1902.
14. Taylor CR, Shi SR, Chaiwun B, Young L, Imam S, Cote R). Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections. Hum ftfhoJ. 1994;25:263-270.
15. Koenig Jl, Snow K, Clark BD, et al. Intrinsic pituitary interleukin-1β is induced by bacterial lipopolysaccharide. Endocrinology. 1990;126:3053-3058.
16. Bateman A, Singh A, Krai T, Solomon S. The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev. 1989;1 0:92-112.
17. Vankelecom H, Carmeliet P, Van Damme J, Billow A,. Denef C. Production of interleukin-6 by folliculostellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system. Neumendocrinology. 1989;49:102-106.
18. Jones TH, Daniels M, James RA, et al. Production of bioactive and immunoreactive interleukin-6 (IL-6) and expression of IL-6 messenger ribonucleic acid by human pituitary adenomas. J Clin Endocrinol Melab. 1994;78:180-187.
19. Velkeniers B, Vergani P, Trouillas J, D'Haens J, Hooghe RJ, Hooghe-Peters EL. Expression of IL-6 mRNA in normal rat and human pituitary adenomas. J H/stochern Cytochem. 1994;42:67-76.
20. Tsagarakis S, Kontogeorgos G, Giannou P, et al. Interleukin-6, a growth promoting cytokine, is present in human pituitary adenomas: an immunocytochemical study. Clin Endocrinol. 1992;37:163-167.
21. Arzt E, Stelzer G, Renner U, Lange M, Muller OA, Stalla GK. lnterleukin-2 and interleukin-2 receptor expression in human corticotropic adenoma and murine pituitary cell cultures. ; Clin Invest. 1992;90:1944-1951.
22. Bristulf J, Simoncsits A, Bartfai T. Characterization of a neural interIeukin-1 receptor and the corresponding mRNA in the mouse anterior pituitary cell line AtT-20. Neurosci Lett. 1991;128:173-176.
23. Ohmichi M, Hirota K. Koike K, Kurachi H, Ohtsuka S, Matsuzaki N. Binding sites for interleukin-6 in the anterior pituitary gland. Neuroendocrinotogy. 1992;55:199-203.
24. Hermus ARMM, Sweep CGJ. Cytokines and the hypothalamic-pituitaryadrenal axis. J Steroid Biochem Mol Biol. 1990;37:867-871.
25. Besedovsky H, Del Rey A. Immune-neuroendocrine circuits: integrative role of cytokines. Front Neuroendocrinol. 1992;13:6l-94.
26. Calandra T, Bernhagen J, Metz CN, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature. 1995;377:68-71.
27. Arzt E, Buric R, Stelzer G, et al. Interleukin involvement in anterior pituitary cell growth regulation: effects of IL-2 and IL-6. Endocrinology. 1993;132: 459-467.